Beta-Blocker Therapy Preserves Normal Splenic T-Lymphocyte Numbers Reduced in Proportion to Sepsis Severity in a Sepsis Model
Joint Authors
Suzuki, Takeshi
Nagata, Hiromasa
Yamada, Takashige
Morisaki, Hiroshi
Inoue, Kei
Igarashi, Toru
Kato, Jungo
Minamishima, Shizuka
Source
Critical Care Research and Practice
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-12-11
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
Lymphocyte cell death contributes to sepsis-induced immunosuppression, leading to poor prognosis.
This study examined whether sepsis severity and beta-blocker therapy could affect the degree of T-lymphocyte cell death in a mouse model of sepsis.
In the first control study, 20 animals were allocated to 4 groups: control group with sham operation (group C, n = 5) and 3 groups with cecum ligation and puncture (CLP) performed at 3 different sites: proximal, middle, and distal cecum (groups CLP-P, CLP-M, and CLP-D, respectively; n = 5 in each group).
Their spleens were resected under general anesthesia 24 hours after CLP, and the total number of normal splenic T lymphocytes per mouse and the percentage of apoptotic T lymphocytes were evaluated using flow cytometry.
In the second experimental study, the effect of the beta-blocker esmolol was examined in CLP-P (group CLP-PE vs.
CLP-P; n = 5 in each group).
The total normal splenic T-lymphocyte numbers per mouse significantly decreased in proportion to CLP severity (group C, 18.6 × 106 (15 × 106–23.6 × 106); CLP-D, 9.2 × 106 (8.8 × 106–9.8 × 106); CLP-M, 6.7 × 106 (6.3 × 106–7.0 × 106); and CLP-P, 5.3 × 106 (5.1 × 106–6.8 × 106)).
Beta-blocker therapy restored T-lymphocyte numbers (group CLP-PE vs.
CLP-P; 6.94 ± 1.52 × 106 vs.
4.18 ± 1.71 × 106; p=0.027) without affecting apoptosis percentage.
Beta-blocker therapy might improve sepsis-induced immunosuppression via normal splenic T-lymphocyte preservation.
American Psychological Association (APA)
Suzuki, Takeshi& Inoue, Kei& Igarashi, Toru& Kato, Jungo& Nagata, Hiromasa& Yamada, Takashige…[et al.]. 2019. Beta-Blocker Therapy Preserves Normal Splenic T-Lymphocyte Numbers Reduced in Proportion to Sepsis Severity in a Sepsis Model. Critical Care Research and Practice،Vol. 2019, no. 2019, pp.1-5.
https://search.emarefa.net/detail/BIM-1129131
Modern Language Association (MLA)
Suzuki, Takeshi…[et al.]. Beta-Blocker Therapy Preserves Normal Splenic T-Lymphocyte Numbers Reduced in Proportion to Sepsis Severity in a Sepsis Model. Critical Care Research and Practice No. 2019 (2019), pp.1-5.
https://search.emarefa.net/detail/BIM-1129131
American Medical Association (AMA)
Suzuki, Takeshi& Inoue, Kei& Igarashi, Toru& Kato, Jungo& Nagata, Hiromasa& Yamada, Takashige…[et al.]. Beta-Blocker Therapy Preserves Normal Splenic T-Lymphocyte Numbers Reduced in Proportion to Sepsis Severity in a Sepsis Model. Critical Care Research and Practice. 2019. Vol. 2019, no. 2019, pp.1-5.
https://search.emarefa.net/detail/BIM-1129131
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1129131